108P Real-world (RW) effectiveness and safety of adjuvant nivolumab (NIVO) in patients (pts) with melanoma in Belgium and Luxembourg: PRESERV MEL
| Autor: | Neyns, B., Willemot, L., McDonald, L., Van Campenhout, H., Berchem, G., Jacobs, C., Rogiers, A., Blockx, N., Rorive, A. |
|---|---|
| Zdroj: | In Immuno-Oncology and Technology December 2023 20 Supplement |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|